A-share announcement highlights | Shenzhen YHLO Biotechnology (688575.SH) being investigated by the China Securities Regulatory Commission for suspected illegal disclosure of information.

Today's Focus 1, Jiangsu Hengrui Pharmaceuticals: HRS-4642 Injection included in the list of breakthrough therapeutic varieties, currently no similar drugs approved for market at home and abroad Jiangsu Hengrui Pharmaceuticals announced on February 6th that the company's HRS-4642 injection has been included in the list of breakthrough therapeutic varieties by the Drug Evaluation Center of the National Medical Products Administration. It is intended for use in combination with gemcitabine and albumin-bound paclitaxel for first-line treatment of advanced or metastatic pancreatic cancer carrying the KRAS G12D mutation. As of now, the company has invested approximately 254 million yuan in related projects. According to the inquiry, there are currently no similar drugs approved for market at home and abroad. 2, Zhejiang Fenglong Electric: If the company's stock price continues to rise abnormally in the future, the company may apply for trading suspension for investigation again Zhejiang Fenglong Electric announced on February 6th that the company's stock price has increased by 491.97% from December 25, 2025, to February 5, 2026, with multiple instances of abnormal stock trading volatility during this period. The company's stock price has experienced a huge increase in the short term, accumulating significant trading risks far exceeding market trends, posing a risk of rapid price decline. If the company's stock price continues to rise abnormally in the future, the company may apply for trading suspension for investigation to the Shenzhen Stock Exchange. Investors are advised to invest rationally and pay attention to investment risks. 3, Aier Eye Hospital Group: Xiangyang Hengtaikang reported by the media has no relation to the company Aier Eye Hospital Group issued a clarification announcement on February 6th, stating that Xiangyang Hengtaikang reported by the media is not a subsidiary of the company but a fourth-level subsidiary established in joint venture with other investors by Aier Medical Investment Group, managed by its hospital management team. The company has no relationship with Hunan Hengtaikang Rehabilitation Medical Industry Development Co., Ltd., and its affiliated institutions. The company and the actual controller Mr. Chen Bang have always adhered to legal and compliant operations, with a "zero tolerance" attitude towards any illegal or irregular behavior. 4, Sunwoda Electronic: Subsidiary reaches settlement with Weir Electric, expected to impact 2025 net profit attributable to parent company by 500 million to 800 million yuan Sunwoda Electronic announced on February 6th that its subsidiary Sunwoda Electronic Power (defendant) has reached a settlement with Weir Electric (plaintiff) in the first instance and signed a "Settlement Agreement". The plaintiff will withdraw the lawsuit after the "Settlement Agreement" takes effect. The plaintiff's claim amount in the case was 2.314 billion yuan. According to the "Settlement Agreement", the actual costs will be determined by both parties, taking into account the relevant warranty deposits that the company has provided, the realizable value of the battery packs after the incident, and potential related expenses that may occur later, which is expected to impact the company's 2025 net profit attributable to the parent company by 500 million to 800 million yuan. 5, Tanac Automation: Eight creditors of former controlling subsidiary file a lawsuit against the company, involving an amount of 108 million yuan Tanac Automation announced on February 6th that on February 5, 2026, the company received a "Civil Complaint" provided by the bankruptcy liquidator of its former controlling subsidiary, Shenzhen Youfu Intelligent Equipment Co., Ltd. Eight creditors of Youfu Intelligent jointly filed a lawsuit against the company. The plaintiffs are all creditors of Youfu Intelligent, and the defendants are the major shareholder of Youfu Intelligent, holding 70% of Youfu Intelligent's equity. The main reason for the plaintiff's objection is that the defendant's "loan" to Youfu Intelligent is actually a capital injection and should not accrue interest, as it should not be classified as ordinary debt but inferior to ordinary debts for repayment. 6, Hubei DOTI Micro Technology: Intends to invest 400 million yuan to build a global R&D center and South China manufacturing headquarters project, mainly engaged in R&D of precise optical components for optical communications Hubei DOTI Micro Technology announced on February 6th that the company intends to sign a "Project Investment Agreement" with the People's Government of Changping Village, Daojiao Town, Dongguan City, planning to invest in the construction of the "Hubei DOTI Micro Technology Global R&D Center and South China Manufacturing Headquarters Project" in Changping Village, Daojiao Town, Dongguan City. The total investment amount of the project is 400 million yuan, to be implemented by the company's wholly-owned subsidiary, Guangdong Hubei DOTI Micro Technology Intelligent Technology Co., Ltd. The planned investment amount for the project is 400 million yuan, mainly engaged in the research, development, manufacturing, and sales of consumer electronics and precise optical components for optical communications. 7, Guangdong Lvtong New Energy Electric Vehicle Technology: Green Passage Industry Fund plans to invest 10 million yuan in Senhao Optoelectronics, which mainly operates optical communication chip testing equipment Guangdong Lvtong New Energy Electric Vehicle Technology announced on February 6 that the Green Passageway Industrial Fund plans to invest 10 million yuan in Senhao Optoelectronics jointly with 13 investors such as affiliated companies Chuangyumingjing and Chuangyumingsheng, subscribing for an additional registered capital of 802,600 yuan, and after the capital increase, it will hold 0.6754% equity in Senhao Optoelectronics. Senhao Optoelectronics' main business is the research, development, manufacturing, and sales of optical communication chip testing equipment, and it also provides subcontracting services for chip testing based on the self-developed equipment. In the past three years, Senhao Optoelectronics' optical chip testing equipment shipment volume has continuously ranked among the top in the country and has established cooperation with several leading optical chip companies in China. In terms of testing subcontracting, as downstream high-speed optical chip production capacity expands, the subcontracting business has grown rapidly and has become an important source of income for Senhao Optoelectronics. 8, Changzhou Tiansheng New Materials Group: Investigation initiated by China Securities Regulatory Commission for suspected violations of information disclosure Changzhou Tiansheng New Materials Group announced on February 6 that the company has received a notice from the China Securities Regulatory Commission initiating an investigation into the company for suspected violations of information disclosure. This investigation may involve undisclosed related party transactions for the year 2023. Currently, the company's production and operations are normal, and the investigation will not have a significant impact on the company's normal production and operation. The company will actively cooperate with the investigation and strictly fulfill its information disclosure obligations. 9, Shenzhen YHLO Biotech: Investigation initiated by China Securities Regulatory Commission for suspected violations of information disclosure Shenzhen YHLO Biotech announced on February 6 that the company has received a "Notice of Investigation" from the China Securities Regulatory Commission on February 6, 2026, initiating an investigation into the company for suspected violations of information disclosure, and in accordance with the laws and regulations, the China Securities Regulatory Commission has decided to initiate a case against the company. 10, Shanghai LongYun Cultural Creation & Technology Group: Intends to purchase 58% equity of Yuheng Film Industry, stock to resume trading next Monday Shanghai LongYun Cultural Creation & Technology Group announced on February 6 that the company intends to purchase a total of 58% equity of Yuheng Film Industry held by Shanghai Bingchang and Duan Zekun through the issuance of shares. Considering the target company's past performance, the overall valuation of the target company is estimated to be between 450 million yuan and 530 million yuan. The target company's main business includes variety show production, TV drama production, live streaming e-commerce, and short video production. After this transaction, the main business of the listed company will extend to the "full chain of content production", adding a core sector of film and television content production and operation. The company's stock is scheduled to resume trading on February 9, 2026. 11, National Silicon Industry Group: National Big Fund plans to reduce its holding of company shares by no more than 3% National Silicon Industry Group announced on February 6 that the National Integrated Circuit Industry Investment Fund Co., Ltd. plans to reduce its stake by no more than 99.15 million shares of the company, accounting for no more than 3% of the company's total share capital, through block trades or centralized bidding within 3 months after 15 trading days from the date of this announcement. 12, Perfect World: Actual controller Chi Yufeng has reduced his stake by 1.70% Perfect World announced on February 6 that from January 5, 2026, to February 6, Chi Yufeng, the actual controller, has reduced his stake by 19.3996 million shares through block trades at an average price of 17.92 yuan per share, accounting for 1.00%; and by reducing 13.5797 million shares through bulk trades at an average price of 17.34 yuan per share, accounting for 0.70%; with a total reduction of 32.9793 million shares, accounting for 1.70%, consistent with the maximum planned disclosed on November 28, 2025, of 32.9795 million shares; the price range of reduction is 16.62 yuan per share to 19.57 yuan per share, this reduction plan (883921) has been completed. 13, Tangshan Sunfar Silicon Industries: Shareholder Yuanheng Technology plans to reduce its stake by no more than 3% Tangshan Sunfar Silicon Industries announced on February 6 that as of the disclosure date, its shareholder Tangshan Yuanheng Technology Co., Ltd. holds 101 million shares of the company's unrestricted shares, accounting for 26.3873% of the total share capital. Yuanheng Technology plans to reduce its stake by no more than 3% by up to 3.826 million shares (1%) through block trades from March 9, 2026, to June 8, 2026, and up to 7.652 million shares (2%) through bulk trades, with a total not exceeding 11.478 million shares (3%). The source of the shares to be divested is obtained before IPO and obtained through equity distribution and is required for self-financing needs. Performance forecast/quick report 1, New Hope Liuhe: Sold 1,121,800 pigs in January, with sales revenue of 1.628 billion yuan 2, Dongrui Food Group: Pig sales revenue in January was 214 million yuan, up 25.19% month-on-month 3, Jiangsu Lihua Foods Group: Sold 48.4628 million meat chickens in January, with sales revenue of 1.289 billion yuan 4, Avary Holding: Consolidated operating income in January decreased by 0.07% year-on-year 5, Hunan Zhenghong Science And Technology Develop: Pig sales revenue in January was 14.3468 million yuan, a year-on-year increase of 7.74% 6, TianYu Bio-Technology: Sold 45,500 pigs in January, with sales revenue of 54.2877 million yuan Buyback & Increase/Reduction of Holdings 1, Anhui Expressway: Plans to invest 5.42 billion yuan in the construction of the G30 Lianhuo Expressway Anhui section expansion project 2, Jiangsu Lianhuan Pharmaceutical: Plans to increase capital by 50 million yuan for its wholly-owned subsidiary 3, ZTE Corporation: Plans to subscribe to 200 million yuan worth of shares of the Guangdong-Hong Kong-Macao Greater Bay Area Entrepreneurship Investment Guidance Fund Partnership Enterprises 4, Tangshan Sunfar Silicon Industries: Shareholder Yuanheng Technology plans to reduce its stake by no more than 3% 5, SBT Ultrasonic Technology: Jianlin Entermanagement and Duan Zhongfu have reduced their stake by 1.5735% Large Order Signing 1, QiaoYin City Management: Pre-awarded approximately 73.8 million yuan for the Urban Integrated Environmental Sanitation Service Project in Xincheng District, Hohhot City, Inner Mongolia Autonomous Region 2, Henan Tong-Da Cable: Pre-awarded National Grid projects with a total value of 188 million yuan 3, Dalian Insulator Group: Pre-awarded contract worth approximately 1.19 billion yuan 4, Guangdong Songfa Ceramics: Recently signed contracts for the construction of four vessels by its subordinate companies Other 1, Chongqing Lummy Pharmaceutical: Wholly-owned subsidiary's Sodium Lactate Ringer's Injection approved for drug supplementary application 2, SHUI ON LAND: Signing a cooperation agreement with China Life Insurance Trust constitutes a related party transaction Source: Tencent Stock Selection; GMTEight Editor: Huang Xiaodong.